评估自行采集的家庭拭子数据在提高全科医疗中流感疫苗有效性估计中的作用
本研究评估了全科医生(GP)发起的、经实验室确认的自行采集家庭拭子数据(iSwab)用于估计流感疫苗有效性(VE)的可行性,并与传统医务人员采集拭子监测数据进行比较。研究比较了两组人群特征,采用检测阴性设计和逻辑回归计算VE。结果显示两种方法在人口学、疫苗接种率和数据完整性上存在差异,合并数据可提供更精确的VE估计,但iSwab队列的人群差异对合并估计的有效性提出质疑。
要点
- ASPREN组中位年龄37岁低于iSwab组42岁,疫苗接种率37%低于iSwab组47%。
- ASPREN组流感阳性率高于iSwab组,尤其在2022年。
- iSwab组2022年因样本量小无法计算VE,2023年VE估计高于ASPREN组。
核心结论
- 全科医生发起的自行采集家庭拭子有潜力补充传统系统用于VE估计。
- 两种方法在人口学、疫苗接种率和数据完整性上的差异突出表明需要系统采样以防止自拭子队列的选择偏倚,以确保在合并数据前VE估计的准确性。
研究设计与样本
- 比较全科医生发起的自行采集家庭拭子(iSwab)患者与既定GP监测网络(ASPREN)中由医务人员采集拭子的患者的人口学、临床和疫苗接种特征。
- 使用检测阴性设计和逻辑回归计算两组VE估计。
主要发现
- ASPREN患者中位年龄37岁低于iSwab患者42岁,疫苗接种率37%低于iSwab组47%。
- iSwab患者比ASPREN队列更可能出现缺失数据。
- 两种采样方法之间病原体检测率存在差异。
- ASPREN流感阳性率高于iSwab,尤其在2022年。
- VE估计在两种方法间存在差异,ASPREN在两年均显示中等有效性;iSwab 2022年因样本量小无法计算VE,2023年VE估计高于ASPREN。
临床怎么用
- 原文未据此给出推荐。
局限性
- iSwab患者比ASPREN队列更可能出现缺失数据。
- iSwab 2022年因样本量小无法计算VE。
- iSwab队列的人群差异对合并估计的有效性提出质疑。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This study evaluated the feasibility of utilising general practitioner (GP)-initiated, laboratory-confirmed self-collected home swab data (iSwab) for estimating influenza vaccine effectiveness (VE), compared to traditional health practitioner-collected swabs for surveillance. Demographic, clinical, and vaccination profiles of iSwab patients were compared to patients whose swabs were collected by a practitioner in an established GP surveillance network (Australian Sentinel Practices REsearch Network, ASPREN). VE estimates for both groups were calculated using a test-negative design and logistic regression. ASPREN patients had a lower median age (37 years) compared to iSwab (42 years) and a lower vaccination rate (37 % vs. 47 %). iSwab patients were more likely to have missing data than the ASPREN cohort. Pathogen detection rates varied between the two sampling methods. ASPREN had higher influenza positivity compared to iSwab, especially in 2022. VE estimates varied between the two methods, with ASPREN demonstrating moderate effectiveness in both years. iSwab VE was unable to be calculated in 2022 due to small sample size, while in 2023 it was higher than the ASPREN estimates. Combining data from both methods provided more precise VE estimates. However, population differences in the iSwab cohort question the validity of the combined estimates. Self-collected home swabs, initiated by GPs, have the potential to complement traditional systems for VE estimation. Differences in demographics, vaccination rates, and data completeness between the two methods highlight the need for systematic sampling to prevent selection bias in the self-swabbing cohort to ensure accuracy of VE estimates before combining data from these two methods.
引用
- Chilver M, Ahsani Z, Sullivan SG, et al. Evaluating the role of self-collected home swab data in enhancing influenza vaccine effectiveness estimates in general practice. Vaccine. 2025. PMID: 41275656. doi:10.1016/j.vaccine.2025.127994
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。